GLP-1 and Muscle Loss in Women: Why It Matters More in Midlife (and How to Protect Yourself)

Jul 13, 2026 | Nutrition and Diet

GLP-1 and Muscle Loss in Women Why It Matters More in Midlife
Sharon Carius - Headshot
Sharon Carius
BA Health Science – Clinical Nutrition, BA App. Sc., Adv Dip Nutritional Medicine, Metabolic Balance® Practitioner, Member of Australian Natural Therapies Association (ANTA)

This article was written with clinical input from Sharon Carius, Clinical Nutritionist and certified Metabolic Balance® Practitioner based in Brisbane, Australia. Sharon works with women navigating insulin resistance, PCOS, and perimenopause through her clinic at WNutrition.

Introduction

If you're a woman on Ozempic®, Mounjaro®, or another GLP-1 medication - or considering one - there's a consequence you need to understand that often gets lost in the excitement about the weight coming off: a significant portion of what you lose can be muscle, not fat. And if you're in your 40s or beyond, this matters far more than the generic advice suggests, because it's landing on top of muscle and bone loss your body is already going through.

This article explains why GLP-1 medications cause muscle loss, why midlife makes it a double hit for women, and - most importantly - how to protect the muscle and bone you need. The medication is your doctor's domain; protecting your body while you're on it is where nutrition does the work.

Why GLP-1 medications cause muscle loss

First, an important clarification: the medication doesn't attack your muscle directly. It's not a toxic effect of the drug. The mechanism is more indirect, and understanding it is the key to preventing it.

GLP-1 medications work by suppressing appetite and slowing digestion, so you eat considerably less. That's the point, and it's effective. But when intake drops sharply - often more sharply than people realise - two things happen: you frequently fall into a significant protein deficit, and your body, needing energy and building blocks, starts breaking down muscle tissue alongside fat to meet its needs.

The scale is genuinely significant. Clinical data consistently show that when protein intake isn't deliberately managed, lean mass can account for around a quarter to as much as 40% of the total weight lost on these medications. In other words, without a plan, a substantial fraction of your "weight loss" can be the muscle you badly need to keep - not the fat you're trying to lose.

Some muscle loss accompanies any weight loss. But GLP-1 medications can accelerate it, because the appetite suppression is so effective that many people end up eating far too little protein to protect their muscle, at exactly the moment they need it most.

Insight

GLP-1 muscle loss isn't the drug damaging your muscle - it's the drug suppressing your appetite so effectively that you stop eating enough protein to protect it. That distinction matters, because it means the problem is largely preventable with the right nutritional approach.

Why this is a double hit for women in midlife

Here's what almost every article on this topic misses, and it's the single most important point for women: if you're perimenopausal or beyond, GLP-1 muscle loss is stacking on top of muscle and bone loss you're already experiencing.

From the mid-30s, women lose muscle gradually, and perimenopause accelerates it as declining oestrogen drives the loss of both muscle and bone. Your body is already, quietly, in a phase of losing the very tissue that keeps you strong, mobile, and metabolically healthy.

Now add a GLP-1 medication that can accelerate muscle loss further, and you have two forces pulling in the same direction at once. The result can be weight loss that leaves a woman lighter but meaningfully weaker - with less muscle, lower bone density, and a slower metabolism - which is close to the opposite of the healthier body most women are hoping for.

This is why the casual "just eat some protein" advice is genuinely inadequate for midlife women. The stakes are higher, the margin is smaller, and protecting muscle and bone isn't optional - it's the whole difference between a GLP-1 making you healthier and making you frailer.

Insight

For a woman in her 40s or 50s, GLP-1 muscle loss doesn't happen in isolation - it compounds the muscle and bone loss of perimenopause. That double hit is why protecting lean mass on these medications matters more for midlife women than for almost anyone else, and why it can't be an afterthought.

Why losing muscle is such a problem

It's worth being clear about why this matters so much, because "losing muscle" can sound abstract until you understand what muscle actually does.

Muscle drives your metabolism. Muscle is metabolically active tissue - it burns energy at rest and is where glucose gets used. Lose muscle and your metabolic rate drops, which makes maintaining weight loss harder and makes the weight regain after stopping the medication more likely and more fat-heavy.

Muscle is strength, function, and independence. Less muscle means declining strength, slower recovery, reduced endurance, and - over the longer term - a real impact on the physical capability and independence that muscle underpins as you age.

Muscle protects your metabolic health. More muscle means better insulin sensitivity and glucose handling. For women already navigating the insulin resistance of perimenopause, losing muscle works directly against metabolic health.

And there's the aesthetic side too. Rapid muscle and fat loss together is part of what drives "Ozempic face" - the hollowing and skin laxity many people notice - because you're losing supportive tissue, not just fat.

So preserving muscle isn't vanity or bodybuilding - it's protecting your metabolism, your strength, your bones, and the durability of your results.

How to protect your muscle on a GLP-1

The good news, as with so much of this, is that GLP-1 muscle loss is largely preventable. The evidence is clear and consistent: combining adequate protein with resistance training is what protects lean mass - and research shows this combination outperforms either one alone, or diet alone, for preserving both muscle and bone.

Prioritise protein - deliberately, not casually

Protein is the raw material your body uses to maintain muscle, and on a GLP-1 it becomes non-negotiable. The challenge is that a suppressed appetite makes protein the hardest thing to eat enough of - protein-rich foods are filling, so they're the first casualty of reduced intake.

The principles that make it work:

  • Anchor every meal with protein first. When you can only eat a little, make those bites the protein - eggs, fish, poultry, Greek yoghurt, legumes, tofu - before anything else.
  • Distribute it across the day. Muscle protection works best with protein spread across meals rather than concentrated in one, which also matters because your reduced appetite limits how much you can eat at once.
  • Your protein needs are higher than usual - and individual. On a GLP-1, in a calorie deficit, ideally resistance training, your protein requirement is meaningfully higher than standard general-population guidance. But the right amount genuinely depends on you - your age, your kidney function, your medical history, your activity - which is exactly why generic gram targets can be misleading or even inappropriate. This is a case where a target set to your body, ideally with clinical input, matters more than a number from an article.

For the fuller picture of eating well on these medications, our guide to what to eat on Ozempic and Mounjaro covers it in depth.

Add resistance training

Protein supplies the building blocks; resistance training supplies the signal that tells your body to keep the muscle. Without that anabolic signal, your body has less reason to preserve lean tissue during weight loss. Strength training - weights, resistance bands, bodyweight work - two to three times a week is the widely recommended starting point, and for midlife women it does double duty, protecting bone density as well as muscle.

Don't lose weight faster than you have to

Rapid weight loss gives your body less opportunity to preserve and rebuild muscle. A more moderate pace, alongside protein and training, protects lean mass better than the fastest possible drop - something worth discussing with the doctor managing your medication.

Why the right approach is specific to you

Everything above is the sound general framework. But the reason it needs personalising - genuinely, not as a sales line - is that the single most important number here, your protein target, depends on factors individual to you: your age, your kidney function, your muscle mass, your activity, your medical history. A generic gram-per-pound figure from an article can be too much for some women and too little for others.

This is where a personalised approach earns its place. Getting the most from a GLP-1 while protecting your body means building a nutrition plan around your individual biochemistry and needs - ensuring you're properly nourished on a reduced appetite, hitting a protein target that's right for you specifically, and protecting the muscle and bone that matter enormously in midlife. It's the foundation of the personalised metabolic and nutrition programmes that help women use these medications well: not just losing weight, but protecting the body and building the metabolic foundation that makes the results last.

Clinical Insight

GLP-1 receptor agonist-associated loss of lean body mass is a clinically significant and, in women, frequently under-addressed consequence of therapy. The mechanism is not direct myotoxicity but rather the consequence of profound appetite suppression producing an energy and - critically - protein deficit of sufficient magnitude that lean tissue is catabolised alongside adipose tissue to meet metabolic demand.
Body-composition data indicate that, absent deliberate intervention, lean mass may constitute approximately 25-40% of total weight lost, a proportion that carries substantial metabolic and functional consequence given the role of skeletal muscle in resting energy expenditure, glucose disposal, and insulin sensitivity. In midlife women this concern is materially amplified: the perimenopausal and postmenopausal decline in oestrogen drives accelerating sarcopenia and reductions in bone mineral density, such that pharmacologically-accelerated lean mass loss is superimposed upon an already catabolic musculoskeletal trajectory, with implications for frailty, fracture risk, and metabolic deterioration.
The evidence base for mitigation is consistent and actionable: adequate protein intake - at levels exceeding general population recommendations, distributed across meals - combined with structured resistance training preserves both muscle and bone more effectively than protein or exercise alone, and substantially more effectively than caloric restriction unaccompanied by either. Protein requirements in this context are elevated but must be individualised, as appropriate targets are modulated by renal function, age, comorbidity, and activity, rendering generic prescriptions potentially inadequate or, in the context of renal impairment, inappropriate.
A moderate rate of weight loss further favours lean mass preservation. The clinical implication is that GLP-1 therapy in women, particularly in midlife, warrants a proactive, individualised nutritional and physical-activity strategy from initiation rather than reactively; the medication itself remains within the prescribing clinician's domain, but body-composition preservation is determined substantially by concurrent nutritional management.

Working With a GLP-1 - Protecting Your Muscle, Not Just Losing Weight?

If you're on a GLP-1 medication, protecting your muscle and bone is what determines whether you end up healthier or simply lighter - and in midlife, that's not something to leave to a generic protein target. My metabolic health programmes work alongside your medical treatment, beginning with a comprehensive analysis of your individual blood chemistry to build a personalised nutrition plan around your body: a protein target that's right for you, meals that keep you properly nourished on a reduced appetite, and a foundation that protects the muscle and bone that matter most in midlife.

For women on a GLP-1 - and especially those who plan, with their doctor, to reduce or come off it in time - this is what protects your body now and makes your results last.

Note: decisions about your medication are between you and your prescribing doctor. This programme focuses on the nutrition that protects your body alongside it.

👉 Book a 1:1 Health Strategy Session

In-clinic and remote consultations available.

Free resource

Download the 7-Day Metabolic Reset Guide - a free, clinically grounded foundation of protein-led eating that supports your metabolism and muscle, whether or not you're on medication. No supplement lists. No extreme protocols. Designed specifically for women.

Frequently Asked Questions


Do GLP-1 medications like Ozempic® cause muscle loss in women?

Yes - without a deliberate plan, a significant portion of weight lost on GLP-1 medications can be muscle rather than fat (research suggests around a quarter to 40%). The drug doesn't damage muscle directly; it suppresses appetite so effectively that many women fall into a protein deficit, and the body breaks down muscle as a result.


Why does GLP-1 muscle loss matter more for women in midlife?

Because it stacks on top of the muscle and bone loss perimenopause already causes. Declining oestrogen accelerates loss of muscle and bone from the late 30s onward, so a GLP-1 that accelerates muscle loss further creates a double hit - which is why protecting lean mass matters more for midlife women.


How do I prevent muscle loss on Ozempic® or Mounjaro®?

The evidence points to two things combined: adequate protein (higher than usual, spread across meals) and regular resistance training. This combination preserves muscle and bone better than either alone. Losing weight at a moderate rather than rapid pace also helps.


How much protein do I need on a GLP-1?

More than standard general guidance - but the right amount genuinely depends on your age, kidney function, medical history, and activity, so a generic target can be misleading. This is a case where a protein target set to your individual needs, ideally with clinical input, matters.


What is "Ozempic® face"?

The hollowing and skin laxity some people notice is driven partly by rapid loss of fat and supportive tissue, including muscle, in the face. Preserving muscle through protein and resistance training helps mitigate it.

Other Articles...

Insulin Resistance and Fatty Liver in Women The Hidden Connection

Insulin Resistance and Fatty Liver in Women: The Hidden Connection

There’s a metabolic condition that affects a large proportion of women with insulin resistance and PCOS – one that progresses silently for years, produces no symptoms until significant damage has occurred, and is almost never checked for at a standard appointment. It’s fatty liver disease, and its connection to insulin resistance is one of the most important and least discussed pieces of the metabolic picture in women’s health.

read more...